Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation

Almut Meyer-Bahlburg; Ellen D. Renner; Stacey Rylaarsdam; Janine Reichenbach; Lena F. Schimke; Amy Marks; Haig Tcheurekdjian; Robert Hostoffer; Archana Brahmandam; Troy R. Torgerson; Bernd H. Belohradsky; David J. Rawlings; Hans D. Ochs

doi:10.1016/j.jaci.2011.09.017

Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation

Almut Meyer-Bahlburg, Ellen D. Renner, Stacey Rylaarsdam, Janine Reichenbach, Lena F. Schimke, Amy Marks, Haig Tcheurekdjian, Robert Hostoffer, Archana Brahmandam, Troy R. Torgerson, Bernd H. Belohradsky, David J. Rawlings, Hans D. Ochs

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Original language	English
Pages (from-to)	559-562.e2
Journal	Journal of Allergy and Clinical Immunology
Volume	129
Issue number	2
DOIs	https://doi.org/10.1016/j.jaci.2011.09.017
State	Published - Feb 2012
Externally published	Yes

Access to Document

10.1016/j.jaci.2011.09.017

Cite this

Meyer-Bahlburg, A., Renner, E. D., Rylaarsdam, S., Reichenbach, J., Schimke, L. F., Marks, A., Tcheurekdjian, H., Hostoffer, R., Brahmandam, A., Torgerson, T. R., Belohradsky, B. H., Rawlings, D. J., & Ochs, H. D. (2012). Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. Journal of Allergy and Clinical Immunology, 129(2), 559-562.e2. https://doi.org/10.1016/j.jaci.2011.09.017

@article{a4c40281b8dd4c3990e719f767bb266a,

title = "Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation",

author = "Almut Meyer-Bahlburg and Renner, {Ellen D.} and Stacey Rylaarsdam and Janine Reichenbach and Schimke, {Lena F.} and Amy Marks and Haig Tcheurekdjian and Robert Hostoffer and Archana Brahmandam and Torgerson, {Troy R.} and Belohradsky, {Bernd H.} and Rawlings, {David J.} and Ochs, {Hans D.}",

note = "Funding Information: Support for this work includes the Habilitationsstipendium f{\"u}r Wissenschaftlerinnen der MHH 2009 and DFG ME2709/2-1 (A.M.-B.), DFG RE2799/3-1 , Fritz-Thyssen research foundation grant ( Az. 10.07.1.159 ) and LMU Munich F{\"o}FoLe grant # 680/658 (E.D.R.), ESID Long-term fellowship 2010 (L.F.S.), NIH grants HD 17427-43 (H.D.O.) and HD037091 (D.J.R.) , the Gebert R{\"u}f Stiftung (J.R.), and a grant of the Jeffrey Modell Foundation (H.D.O.). Funding Information: Disclosure of potential conflict of interest: J. Reichenbach has received research support from the Chronic Granulomatous Disorder Research Trust and the Gebert R{\"u}f Stiftung Program Rare Diseases New Approaches . T. R. Torgerson is a consultant for Baxter Biotherapeutics. H. D. Ochs has received research support from the Jeffrey Modell Foundation and CSL Behring . The rest of the authors declare that they have no relevant conflicts of interest. ",

year = "2012",

month = feb,

doi = "10.1016/j.jaci.2011.09.017",

language = "English",

volume = "129",

pages = "559--562.e2",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "2",

}

Meyer-Bahlburg, A, Renner, ED, Rylaarsdam, S, Reichenbach, J, Schimke, LF, Marks, A, Tcheurekdjian, H, Hostoffer, R, Brahmandam, A, Torgerson, TR, Belohradsky, BH, Rawlings, DJ & Ochs, HD 2012, 'Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation', Journal of Allergy and Clinical Immunology, vol. 129, no. 2, pp. 559-562.e2. https://doi.org/10.1016/j.jaci.2011.09.017

TY - JOUR

T1 - Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation

AU - Meyer-Bahlburg, Almut

AU - Renner, Ellen D.

AU - Rylaarsdam, Stacey

AU - Reichenbach, Janine

AU - Schimke, Lena F.

AU - Marks, Amy

AU - Tcheurekdjian, Haig

AU - Hostoffer, Robert

AU - Brahmandam, Archana

AU - Torgerson, Troy R.

AU - Belohradsky, Bernd H.

AU - Rawlings, David J.

AU - Ochs, Hans D.

N1 - Funding Information: Support for this work includes the Habilitationsstipendium für Wissenschaftlerinnen der MHH 2009 and DFG ME2709/2-1 (A.M.-B.), DFG RE2799/3-1 , Fritz-Thyssen research foundation grant ( Az. 10.07.1.159 ) and LMU Munich FöFoLe grant # 680/658 (E.D.R.), ESID Long-term fellowship 2010 (L.F.S.), NIH grants HD 17427-43 (H.D.O.) and HD037091 (D.J.R.) , the Gebert Rüf Stiftung (J.R.), and a grant of the Jeffrey Modell Foundation (H.D.O.). Funding Information: Disclosure of potential conflict of interest: J. Reichenbach has received research support from the Chronic Granulomatous Disorder Research Trust and the Gebert Rüf Stiftung Program Rare Diseases New Approaches . T. R. Torgerson is a consultant for Baxter Biotherapeutics. H. D. Ochs has received research support from the Jeffrey Modell Foundation and CSL Behring . The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84856448923&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2011.09.017

DO - 10.1016/j.jaci.2011.09.017

M3 - Article

AN - SCOPUS:84856448923

SN - 0091-6749

VL - 129

SP - 559-562.e2

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 2

ER -

Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation

Access to Document

Other files and links

Cite this